First &Only Oral Estrogen Approved by FDA for Vaginal Symptoms During Menoapuse

According to the North American Menopause Society over 6,000 women are reaching menopause every day in North America.. Most women spend 1/3 to 1/2 of their life in post menopause All women will experience menopause. Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. will launch the new indication for Enjuvia, oral estrogen, at North American Menopause Society annual meeting. Enjuvia is the first and only oral estrogen that has been approved by FDA to treat moderate-to-severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. Enjuvia received FDA approval in 2006 for the treatment of moderate- to-severe vasomotor symptoms such as hot flashes and night sweats. More about Dr. Simon: Dr. James Simon is Clinical Professor of Obstetrics and Gynecology at George Washington University in D.C. Dr. Simon maintains a private practice of reproductive endocrinology in Washington, D.C. Dr. Simon is certified by the American Board of Obstetrics and Gynecology in both obstetrics and gynecology, and reproductive endocrinology and infertility. He is also certified by the International Society for Clinical Densitometry (ISCD) and directs a bone densitometry center.